Navigation Links
Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant
Date:7/19/2011

NORTH ATTLEBORO, Mass., July 19, 2011 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a leading regulatory consulting firm and CRO for the medical device industry, announced today that Mr. Brian Edwards has joined the company's regulatory services group as a senior regulatory staff consultant. He will be based in Minneapolis, MN.

Mr. Edwards brings over twenty years of experience in the regulation of medical devices, design and analysis of device trials, biostatistics, quality systems, and US and OUS regulatory submissions. His work spans a broad range of therapeutic areas including work with spinal, audiological, cardiovascular, cardiology, muscle and nerve stimulation, urological, and software/communication devices.  During his previous positions as director of regulatory affairs at Zimmer Spine, Inc., Otologics, LLC, and Stereotaxis, Inc., as well as a senior level position with Medtronic, Inc. he managed regulatory clearances and approvals for Class II and Class III devices in the United States, European Union, Canada, Latin America and Asia. In addition, he is experienced in the implementation and auditing of FDA and ISO compliant quality systems.  

"I am pleased to welcome Brian to our team," said Vicki Anastasi, vice president of regulatory services and business development. "He brings proven regulatory expertise in key therapeutic areas, including cardiovascular, orthopedics and medical device software. Based in Minneapolis, he will amplify MDCI's presence in the important Twin Cities medical device cluster."

Brian holds a B.S. in chemical engineering, and an M.S. in biomedical engineering, both from the University of Minnesota. He also earned an M.S. in biostatistics from the University of California, Los Angeles.  Brian is a member of the Regulatory Affairs Professionals Society (RAPS).

About MDCI

Founded in 1980, MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle.  MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally.  MDCI has offices in Massachusetts and California.  Additional information is available at www.mdci.com.


'/>"/>
SOURCE Medical Device Consultants, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Outlines Oversight of Mobile Medical Applications
2. China Sky One Medical Wins Bidding Process on Land Use Rights Covering Land at Song Bei District in Harbin
3. Key Challenges for Pharma Medical Affairs Functions Include Budget & Headcounts
4. AAPC Physician Services Announces Medical Compliance Toolkit
5. European Medical Displays Markets
6. China Medical Technologies Announces the Filing of its Annual Report on Form 20-F for the Fiscal Year Ended March 31, 2011 with the SEC
7. HASCO Medical Announces New Redesigned Websites for Mobility Freedom and Wheelchair Vans of America
8. Mindray Medical Provides Mid-Year Update on Product Development
9. Aethlon Medical Releases Shareholder Letter
10. Aprima Earns High Marks at Holy Name Medical Center
11. QuantRx Biomedical Corporation Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):